Furthermore, in agreement with PDLIM5 being a functional effector downstream of the HNRNPC–PABPC4 axis, PDLIM5 expression was also associated with survival of patients with breast cancer (Fig. 6h and Extended Data Fig. 6i,j). Here, PDLIM5 is linked to breast cancer.